RICHARD E. LEE; ARTHUR W. SELIGMANN; MELVA A. CLARK; NEMAT O. BORHANI; JOHN T. QUEENAN; MAUREEN E. O'BRIEN
Although the great majority of hypertensive patients can be managed effectively with presently established medical programs,1, 2 instances of failure to respond to treatment in a completely satisfactory manner are not uncommon. In our experience, such patients may include as many as 10% or more of the hypertensive population.3 Major reasons for such "refractoriness" are probably at least twofold: (1) predisposition to intolerance of drug side-effects that prevents use of antihypertensive agents in adequate amounts, and (2) perhaps a more fixed or resistant type of blood pressure elevation that is not amenable to the therapy employed. Within the last
RICHARD E. LEE, ARTHUR W. SELIGMANN, MELVA A. CLARK, NEMAT O. BORHANI, JOHN T. QUEENAN, MAUREEN E. O'BRIEN. THERAPEUTICALLY "REFRACTORY" HYPERTENSION: CAUSATIVE FACTORS, AND MEDICAL MANAGEMENT WITH CHLOROTHIAZIDE AND OTHER AGENTS(THERAPEUTICALLY "REFRACTORY" HYPERTENSION: CAUSATIVE FACTORS, AND MEDICAL MANAGEMENT WITH CHLOROTHIAZIDE AND OTHER AGENTS*). Ann Intern Med. 1958;49:1129–1137. doi: 10.7326/0003-4819-49-5-1129
Download citation file:
Published: Ann Intern Med. 1958;49(5):1129-1137.
Cardiology, Coronary Risk Factors, Hypertension, Nephrology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use